The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Understanding the most appropriate workflow for biochemical human leukocyte antigen (HLA)‐associated peptide enrichment prior to ligand sequencing is essential to achieve optimal sensitivity in immunopeptidomics experiments. The use of different detergents for HLA solubilization as well as complementary workflows to separate HLA‐bound peptides from HLA protein complex components after their immunoprecipitation including HPLC, C18 cartridge, and 5 kDa filter are described. It is observed that all solubilization approaches tested led to similar peptide ligand identification rates; however, a higher number of peptides are identified in samples lysed with CHAPS compared with other methods. The HPLC method is superior in terms of HLA‐I peptide recovery compared with 5 kDa filter and C18 cartridge peptide purification methods. Most importantly, it is observed that both the choice of detergent and peptide purification strategy creates a significant bias for the identified peptide sequences, and that allele‐specific peptide repertoires are affected depending on the workflow of choice. The results highlight the importance of employing a suitable strategy for HLA peptide enrichment and that the obtained peptide repertoires do not necessarily reflect the true distributions of peptide sequences in the sample.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unintentionally, many MHC immunopeptidome analyses are biased due to technical limitations.7,8”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [8]
In the citing paper
“most immunopeptidomic laboratories do not routinely add a cysteine protecting reagent during cell lysis for MHC-IAC.7,8,18,24,27,49,54−57”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [8]
In the citing paper
“even if it was possible to eliminate all biases specific for the MAE or the MHC-IAC workflows, important general biases will remain as, for example, the bias introduced by C18 desalting,8 the loss of very hydrophobic peptides on plastic equipment, and the more prominent detection of peptides with preferable MS ionization properties.”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [8]
In the citing paper
“One critical step that has been differently performed in immunopeptidomic studies since the early 1990s is the separation of MHC peptide ligands from accompanying proteins after elution from the MHC-IAC column.8”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [8]
In the citing paper
“it was very similar to the reported overlaps for MHC-IACs that merely differed in the separation of peptides from MHC proteins and β2m after elution from the MHC-IAC matrix”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 394
Self-citation
Research works printed but not linked: 10
- 10.1097/00002371-199308000-00003 · DOI · Paper page
- 10.1007/s002510050219 · DOI
- 10.1126/science.1546328 · DOI · Paper page
- 10.1038/351290a0 · DOI · Paper page
- 10.1074/mcp.O115.052431 · DOI · Paper page
- 10.1002/pmic.201700251 · DOI · Paper page
- 10.1016/S0021-9258(17)40215-8 · doi:10.1016/s0021-9258(17)40215-8
- 10.1074/mcp.M114.042812 · DOI · Paper page
- 10.1093/nar/gks469 · DOI · Paper page
- 10.1093/bioinformatics/btv639 · DOI · Paper page
Cited by
Sturm, T., Sautter, B., Wörner, T. P., Stevanović, S., Rammensee, H.-G., Planz, O., Heck, A. J. R., & Aebersold, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00386 · Cited by 63
Metadata
- Authors
- Nicastri, A., Liao, H., Muller, J., Purcell, A. W., & Ternette, N.
- Affiliations
- The Jenner Institute Nuffield Department of Medicine University of Oxford Oxford OX3 7BN UK
- Molecular Health GmbH Heidelberg 69115 Germany
- Department of Biochemistry and Molecular Biology and Infection and Immunity Program Biomedicine Discovery Institute Monash University Clayton Victoria 3800 Australia
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2020-06
- Volume
- 20
- Issue
- 12
- ISSN
- 1615-9853
- 1615-9861
- Cited by
- 25
- References
- 1
- Language
- en
- Update notices
- correction (2020-12-16)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire. https://app.cochat.ai/papers/10.1002/pmic.201900401
- The paper
- Nicastri, A., Liao, H., Muller, J., Purcell, A. W., & Ternette, N. (2020). The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire. PROTEOMICS. https://doi.org/10.1002/pmic.201900401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.